Showing 741-750 of 3359 results for "".
Considering Aesthetic Combinations
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/considering-aesthetic-combinations/19684/Whether it's the use of two or more devices or the addition of fillers or neurotoxins to device-based treatments, combination approaches can improve outcomes and potentially reduce downtime, Nazanin Saedi, MD explains.Antiaging Medicine Meets Aesthetics
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/antiaging-medicine-meets-aesthetics/18883/Antiaging medicine supports overall patient health and can be a complement to aesthetic medicine. Greg Buford, MD talks about anti aging medicine and its role in his practice.Positive Changes in My Practice
https://practicaldermatology.com/topics/practice-management/positive-changes-in-my-practice/19044/Sometimes relatively simple changes can have a big impact on a practice. Steve Yoelin, MD talks about positive changes he has made in his practice.Management of the Periocular Area
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/management-of-the-periocular-area/19210/Richard Anderson, MD reviews his presentation on the proper approach to cosmetic management of the periocular area and mid-face at Vegas Cosmetic Surgery 2013. He discusses blepharoplasty, toxins, fillers, and more. VCS2013Prurigo Nodularis in Skin of Color: Recognizing Distinct Clinical Presentations
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/prurigo-nodularis-in-skin-of-color-recognizing-distinct-clinical-presentations/57012/Cheri Frey, MD, discusses how prurigo nodularis may present differently in patients with skin of color, highlighting diagnostic challenges, variations in inflammation, and the importance of recognizing disease manifestations across diverse skin tones.TOGETHER-PsO: Dual Therapy for Psoriasis and Obesity
https://practicaldermatology.com/videos/skin-minute/together-pso-dual-therapy-for-psoriasis-and-obesity/57262/Mark G. Lebwohl, MD, provides key takeaways and commentary on the results of the TOGETHER-PsO study, which looked at a combination therapy of ixekizumab (Taltz) and tirzepatide (Zepbound) in patients with both psoriasis and obesity.Oral Hair Supplements and Sunscreens
https://practicaldermatology.com/series/music-city-scale/oral-hair-supplements-and-sunscreens/57223/Zoe Dian Draelos, MD, provides highlights from her two talks at Music City SCALE 2026, about oral hair supplements and sunscreens, including apps that evaluate products.Analyzing Recent Deuruxolitinib Data
https://practicaldermatology.com/series/skin-minute/analyzing-recent-deuruxolitinib-data/57165/Arash Mostaghimi, MD, MPH, FAAD, Vice Chair of Clinical Trials and Innovation for the Brigham & Women's Hospital Department of Dermatology, discusses reently released data on deuruxolitinib for the treatment of alopecia areata.How to Humanize Medicine
https://practicaldermatology.com/conferences/noah-worcester/how-to-humanize-medicine/57074/Michael Greenberg, MD, discusses his presentation, “What I Would Teach Residents – Humanizing Medicine,” from the Noah Worcester Dermatological Society’s 2026 Annual Meeting.Behavioral Interview Considerations
https://practicaldermatology.com/conferences/noah-worcester/behavioral-interview-considerations/57077/Robert Brodell, MD, discusses his presentation, “Helping Students 'Ace' their Behavioral Interview for Medical School or Residency,” from the Noah Worcester Dermatological Society’s 2026 Annual Meeting.